Immunocore Holdings IMCR
NASDAQ IMCR
$29.76 -0.78 (-2.55%)
As of: Oct 2, 2026 · 12:02 PM EDT

Immunocore Holdings (IMCR) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Immunocore Holdings (IMCR) recorded Net Equity Issued and Repurchased of $16.49 million in Q2 2026, up 349.2% from $3.67 million a year earlier.

Analysis

Immunocore Holdings (IMCR) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

On a TTM basis, Immunocore Holdings' Net Equity Issued and Repurchased came in at $23.29 million as of Jun 30, 2026, up 234.2% year-over-year; for FY2025, it came in at $12.37 million, up 81.9% from FY2024.

  • Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of -54.4% (FY2021 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $6.8 million in FY2024 (-80.2%), $34.35 million in FY2023 (-75.4%), $139.52 million in FY2022 (-51.4%) and $286.89 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2023.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last seven quarters, with growth averaging 221.6%.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 842.4% in Q3 2025, against a decline of 98.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $656,000 (Q1 2026), $4.28 million (Q4 2025) and $1.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Immunocore Holdings 1.56 Bn -1.92 Bn 114.84 Mn 16.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.49 Mn
Mar 31, 2026 656,000.00
Dec 31, 2025 4.28 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 3.67 Mn
Mar 31, 2025 2.55 Mn
Dec 31, 2024 550,000.00
Sep 30, 2024 198,000.00
Jun 30, 2024 298,000.00
Mar 31, 2024 5.75 Mn
Dec 31, 2023 6.25 Mn
Sep 30, 2023 10.38 Mn
Jun 30, 2023 11.58 Mn
Mar 31, 2023 6.14 Mn
API Access

Immunocore Holdings Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMCR&period=max&api_key=YOUR_API_KEY